fda glp-1 compounding crackdown news National Hispanic Medical Association | The federal government is stepping up to stop counterfeit weight-loss drugs. In 2025, bipartisan lawmakers urged stronger enforcement FDA Targets Telehealth Compounded GLP-1

Choung YH, Kim SW, Tian C, et al

Some people pop off a square and chase it with water before a meal

Ipamorelin is considered selective, meaning it is associated with less appetite stimulation and cortisol elevation than older, less targeted growth hormone secretagogues

In June 2021, the FDA approved a higher-dose formulation of semaglutidemarketed under the brand name Wegovyspecifically for chronic weight management in adults with obesity or those who are overweight and have at least one weight-related health condition, such as type 2 diabetes, high blood pressure, or high cholesterol

Clinical pharmacokinetics of drugs in obesity